Virax Biolabs Group Ltd — Form D
Virax Biolabs Group Ltd of Lanarkshire, X0, a company, filed a Form D exempt-offering notice with the SEC on 2023-10-17. The offering totals $2.1M, of which $2.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-10-17
- Form: D
- Accession: 0001209191-23-052944
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.1M
- Amount sold: $2.1M
- Investors: 1
- Date of first sale: 2023-10-12
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-495026
Issuer
- Name: Virax Biolabs Group Ltd
- CIK: 0001885827
- Entity type: Corporation
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2021
- Address: BioCity Glasgow, Bo'Ness Road Newhouse, Lanarkshire, X0, ML1 SUH
- Phone: 44 020 7788 7414
Officers, directors & promoters (20)
| Name | Role | Location |
|---|
| Yair Alexander Cunliffe Erez | Director | London, X0 |
| James Alexander Cunliffe Foster | Director | London, X0 |
| Nelson Maurice Haight | Director | London, X0 |
| Evan Alexander Cunliffe Norton | Director | London, X0 |
| Mark Alexander Cunliffe Ternouth | Director | London, X0 |
| Jason Maurice Davis | Executive Officer | London, X0 |
| James Alexander Cunliffe Foster | Executive Officer | London, X0 |
| Nigel Alexander Cunliffe McCracken | Executive Officer | London, X0 |
| Mark Alexander Cunliffe Ternouth | Executive Officer | London, X0 |
| Yair Erez | Director | Lanarkshire, X0 |
| Evan Norton | Director | Wilmette, IL |
| Nigel McCracken | Director | Lanarkshire, X0 |
| Nigel McCracken | Executive Officer | Lanarkshire, X0 |
| James Foster | Director | Lanarkshire, X0 |
| James Foster | Executive Officer | Lanarkshire, X0 |
| Nelson Haight | Director | Lanarkshire, X0 |
| Cameron Alexander Cunliffe Shaw | Director | London, X0 |
| Cameron Alexander Cunliffe Shaw | Executive Officer | London, X0 |
| Tomasz Maurice George | Executive Officer | London, X0 |
| Mark Maurice Ternouth | Executive Officer | London, X0 |
Other filings by this issuer (2)
More